Similar articles

• Systolic Hypertension in the Elderly Program (SHEP). Part 6: Baseline physical examination findings.

  Black HR, Unger D, Burlando A, Wright JC, Pressel SL, Allen R, McDonald RH, Surath H. Black HR, et al. Hypertension. 1991 Mar;17(3 Suppl):II77-101. doi: 10.1161/01.hyp.17.3_suppl.ii77. Hypertension. 1991. PMID: 1999377 Clinical Trial. No abstract available.
• Systolic Hypertension in the Elderly Program (SHEP). Part 8: Electrocardiographic characteristics.

  Kostis JB, Prineas R, Curb JD, Lee M, Berkson D, Raines J, Frishman W, Francis CK, Sheffield T. Kostis JB, et al. Hypertension. 1991 Mar;17(3 Suppl):II123-51. doi: 10.1161/01.hyp.17.3_suppl.ii123. Hypertension. 1991. PMID: 1825649 Clinical Trial. No abstract available.
• Systolic Hypertension in the Elderly Program (SHEP). Part 7: Baseline laboratory characteristics.

  Hall WD, Davis BR, Frost P, Hoffmeier M, O'Brien JE, Pace S, Page L, Schneider KA, Stamler J. Hall WD, et al. Hypertension. 1991 Mar;17(3 Suppl):II102-22. doi: 10.1161/01.hyp.17.3_suppl.ii102. Hypertension. 1991. PMID: 1999369 Clinical Trial. No abstract available.
• Improved outcomes with antihypertensive medication in the elderly with isolated systolic hypertension.

  Wang JG, Staessen JA. Wang JG, et al. Drugs Aging. 2001;18(5):345-53. doi: 10.2165/00002512-200118050-00005. Drugs Aging. 2001. PMID: 11392443 Review.
• The benefit of treating isolated systolic hypertension.

  Wang JG, Staessen JA. Wang JG, et al. Curr Hypertens Rep. 2001 Aug;3(4):333-9. doi: 10.1007/s11906-001-0096-5. Curr Hypertens Rep. 2001. PMID: 11470016 Review.